J. I. Silverberg and J. M. Hanifin, Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population-based study, J Allergy Clin Immunol, vol.132, issue.5, pp.1132-1140, 2013.

J. P. Kim, L. X. Chao, E. L. Simpson, and J. I. Silverberg, Persistence of atopic dermatitis (AD): A systematic review and meta-analysis, J Am Acad Dermatol, vol.75, issue.4, pp.681-687, 2016.

A. Wollenberg, A. Oranje, M. Deleuran, D. Simon, Z. Szalai et al.,

E. Eadv, Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients, J Eur Acad Dermatol Venereol, vol.30, issue.5, pp.729-776, 2016.

C. R. Totri, L. F. Eichenfield, K. Logan, L. Proudfoot, J. Schmitt et al., Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey, J Am Acad Dermatol, 2017.

C. Goujon, M. Viguier, D. Staumont-sallé, C. Bernier, G. Guillet et al.,

, Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial, J Allergy Clin Immunol Pract, 2017.

M. A. El-khalawany, H. Hassan, D. Shaaban, N. Ghonaim, and B. Eassa, Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt, Eur J Pediatr, vol.172, issue.3, pp.351-357, 2013.

A. Védie, K. Ezzedine, E. Amazan, F. Boralevi, B. Milpied et al., Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study, Acta Derm Venereol, vol.96, issue.6, pp.802-808, 2016.

F. M. Garritsen, E. Roekevisch, J. Van-der-schaft, J. Deinum, P. I. Spuls et al., Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres, 13. van den Reek JMPA, vol.29, pp.1-5, 2015.

A. Menter, M. Gooderham, . Pariser-d-m, and M. Augustin, Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR), J Eur Acad Dermatol Venereol, vol.30, issue.7, pp.1621-1628, 2015.

J. Daguzé, H. Aubert, C. Bernier, A. Gaultier, J. Nguyen et al.,

, Monocentric Retrospective Cohort of Patients with Severe Atopic Dermatitis Treated with Cyclosporine A in Daily Practice, Acta Derm Venereol, vol.97, issue.8, pp.955-961, 2017.

K. Politiek, J. Van-der-schaft, P. J. Coenraads, M. S. De-bruin-weller, and M. Schuttelaar, Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis, Br J Dermatol, vol.174, issue.1, pp.201-204, 2016.

S. B. Vercauteren, J. L. Bosmans, M. M. Elseviers, G. A. Verpooten, D. Broe et al., A metaanalysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases, Kidney Int, vol.54, issue.2, pp.536-581, 1998.

C. F. Paul, V. C. Ho, C. Mcgeown, E. Christophers, B. Schmidtmann et al., Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study, J Invest Dermatol, vol.120, issue.2, pp.211-217, 2003.

. Granlund-h-akan, P. Erkko, M. Sinisalo, and S. Reitamo, Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy, Br J Dermatol, vol.132, issue.1, pp.106-112, 1995.

. Harper-j-i, I. Ahmed, G. Barclay, M. Lacour, P. Hoeger et al., Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy, Br J Dermatol

E. L. Simpson, M. Bruin-weller, C. Flohr, A. , M. R. Barbarot et al., When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council, J Am Acad Dermatol, vol.77, issue.4, pp.623-656, 2017.

J. R. Chalmers, J. Schmitt, C. Apfelbacher, M. Dohil, L. F. Eichenfield et al., Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME), Br J Dermatol, vol.171, issue.6, pp.1318-1343, 2014.